Scientists recently uncovered the reason why patients with Huntington’s disease have up to 80 percent less cancer than the general population,…
Patricia Inácio, PhD
Patricia holds her PhD in cell biology from the University Nova de Lisboa, Portugal, and has served as an author on several research projects and fellowships, as well as major grant applications for European agencies. She also served as a PhD student research assistant in the Department of Microbiology & Immunology, Columbia University, New York, for which she was awarded a Luso-American Development Foundation (FLAD) fellowship.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Patricia Inácio, PhD
Nerve cells contain proteins that send signals to other cells and proteins that receive neighboring cells’ signals. Researchers at…
uniQure expects to advance the clinical development of its Huntington’s disease investigational gene therapy, called AMT-130, during 2018. The company…
Aberrant metabolism of urea is a potential first event promoting Huntington’s disease (HD), a study with a sheep model and…
Researchers have found that rilmenidine, a blood pressure medicine, was relatively safe and well-tolerated by Huntington’s disease (HD) patients in…
Researchers have identified an elaborate protein quality control system that prevents toxic accumulation of faulty proteins inside mitochondria, a phenomenon…
As therapeutics for Huntington’s disease (HD) are still a need, a number of natural compounds may hold promising beneficial effects,…
Huntington’s disease causes hearing problems, a study with a small sample size suggests. The research, “Auditory dysfunction in patients…
Researchers generated the first human line of Huntington’s disease induced pluripotent stem cells (iPSCs) that do not express the dysfunctional…
Researchers used gene editing to suppress the activity of protein mutations in the brains of mice with Huntington’s disease. Suppressing…